“…In recent past, 2,4,6-trisubstituted-1,3,5-triazine scaffolds were discovered as a potent inhibitors of Mycobacterium tuberculosis (Mtb) H37Rv [10]. Currently 1,3,5-triazine derivatives have been found to possess wide range of biological activities, such as adenosine receptor antagonist [11], antiamoebic [12], anticancer [13], antileishmanial [14], antimalarial [15], antimicrobial [16], antiviral [17], antitubercular [18], carbonic anhydrase inhibitor [19], cathepsin B inhibitor [20], cholesteryl ester transfer protein inhibitor [21], corticotropin-releasing factor ligand [22], CRF1 PET imaging agent [23], cytosolic phospholipase A2α inhibitor [24], dipeptidyl peptidase IV inhibitor [25], bacterial enzyme DNA helicase inhibitor [26], dual PI3/mTOR inhibitor [27], glucocerebrosidase inhibitor [28], α-glucosidase inhibitor [29], growth factor inhibitor [30], human gonadotropin-releasing hormone receptor antagonist [31], 5-HT7 receptor antagonist [32], inosine monophosphate dehydrogenase inhibitor [33], mTOR kinase inhibitor [34],…”